Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Schiff bases as linker in the development of quinoline-sulfonamide hybrids as selective cancer-associated carbonic anhydrase isoforms IX/XII inhibitors: A new regioisomerism tactic
Afaf El‐Malah, Ehab S. Taher, Andrea Angeli, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106309-106309
Closed Access | Times Cited: 15

Showing 15 citing articles:

A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation
Claudiu T. Supuran
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 93, pp. 129411-129411
Closed Access | Times Cited: 63
A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments
Salma M. Hefny, Tarek F. El‐Moselhy, Nabaweya Sharaf El-Din, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116527-116527
Closed Access | Times Cited: 16
Targeting carbonic anhydrases for the management of hypoxic metastatic tumors
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 11, pp. 701-720
Closed Access | Times Cited: 22
Chemistry of heterocycles as carbonic anhydrase inhibitors: A pathway to novel research in medicinal chemistry review
Anjaneyulu Bendi, Taruna, Rajni Rajni, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 7
Closed Access | Times Cited: 3
New Sulfonate Ester‐Linked Fluorinated Hydrazone Derivatives as Multitarget Carbonic Anhydrase and Cholinesterase Inhibitors: Design, Synthesis, Biological Evaluation, Molecular Docking and ADME Analysis
Berna Akış, Reşit Çakmak, Murat Şentürk
Chemistry & Biodiversity (2024) Vol. 21, Iss. 12
Closed Access | Times Cited: 3
Synthesis and application of diazenyl sulfonamide-based schiff bases as potential BRCA2 active inhibitors against MCF-7 breast cancer cell line
Olia Rezaeianzadeh, Sakineh Asghari, Mahmood Tajbakhsh, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Design and Synthesis of Novel Uracil-Linked Schiff Bases As Dual Histone Deacetylase Type II/topoisomerase Type I Inhibitors With Apoptotic Potential
Samar El‐Kalyoubi, Samar S. Elbaramawi, Ahmed G. Eissa, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 11, pp. 937-958
Closed Access | Times Cited: 7
Discovery of novel 1,8-naphthalimide piperazinamide based benzenesulfonamides derivatives as potent carbonic anhydrase IX inhibitors and ferroptosis inducers for the treatment of triple-negative breast cancer
Qiaoling Liang, Shi Zhang, Jiajia Liu, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107596-107596
Closed Access | Times Cited: 2
New S‐substituted‐3‐phenyltetrahydrobenzo[4,5]thieno[2,3‐d]pyrimidin‐4(3H)‐one scaffold with promising anticancer activity profile through the regulation and inhibition of mutated B‐RAF signaling pathway
Safaa E. Seif, Wagnat W. Wardakhan, Rasha A. Hassan, et al.
Drug Development Research (2024) Vol. 85, Iss. 7
Open Access | Times Cited: 2
Design and synthesis of uracil/thiouracil based quinoline scaffolds as topoisomerases I/II inhibitors for chemotherapy: A new hybrid navigator with DFT calculation
Samar El‐Kalyoubi, Samar S. Elbaramawi, Wael A. Zordok, et al.
Bioorganic Chemistry (2023) Vol. 136, pp. 106560-106560
Closed Access | Times Cited: 6
Effect of lactic acid bacteria by different concentrations of copper based on non-target metabolomic analysis
Xinlei Li, Shiyue Chen, Lili Zhao, et al.
Environmental Science and Pollution Research (2023) Vol. 30, Iss. 49, pp. 107568-107579
Closed Access | Times Cited: 6
Increased Free Radical Generation during the Interaction of a Quinone-Quinoline Chelator with Metal Ions and the Enhancing Effect of Light
Olga Yu. Selyutina, Simon V. Babenko, Irina A. Slepneva, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1116-1116
Open Access | Times Cited: 5
Current Scenario of Pyridine/Quinoline-Sulfonamide Hybrids with Anticancer Potential (A Review)
Guangbin Dong, Yu Feng, Jeh‐Jeng Wang, et al.
Russian Journal of General Chemistry (2024) Vol. 94, Iss. 4, pp. 989-1005
Closed Access | Times Cited: 1
Recruitment of hexahydroquinoline as anticancer scaffold targeting inhibition of wild and mutants EGFR (EGFR WT , EGFR T790M , and EGFR L858R )
Mahmoud G. Abo Al-Hamd, Haytham O. Tawfik, Omeima Abdullah, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 3
Molecular Modeling, Synthesis, and preliminary pharmacological evaluation of New Sulfonamide Derivatives as Selective Carbonic Anhydrase XII and IX inhibitors (Research)
Samer Tareq Jasim, Monther Faisal Mahdi
Al Mustansiriyah Journal of Pharmaceutical Sciences (2024) Vol. 24, Iss. 2, pp. 137-149
Open Access
Page 1

Scroll to top